Document is current
Any future updates will be listed below
-
Authors
Jones, Gareth T. http://orcid.org/0000-0003-0016-7591
Macfarlane, Gary J.
Forrest Keenan, Karen
McNamee, Paul
Neilson, Aileen R.
Siebert, Stefan
Burden, A. David
Kay, Lesley
Helliwell, Philip S.
-
Funding
Funding for this research was provided by:
British Society for Rheumatology
- License Information
-
More Information
Article History
Received: 28 October 2020
Accepted: 10 March 2021
First Online: 17 May 2021
Declarations
:
: The study was approved by the NHS West of Scotland Research Ethics Committee 3 (reference: 18/WS/0126). All participants provide written informed consent prior to participation in the study.
: Not applicable. The manuscript contains no personal or clinical details of study participants.
: GTJ Has received research grant income from AbbVie, Amgen (previously Celgene), Pfizer, UCB and GSK. GJM Has received research grant income from AbbVie, Amgen (previously Celgene), Pfizer, UCB and GSK. KFK Nil. PM Nil. ARN Nil. SS Has received research grants or honoraria from AbbVie, Amgen (previously Celgene), BMS, Boehringer Ingelheim, GSK, Janssen, Novartis, Pfizer and UCB. ADB Has received research grants or honoraria from AbbVie, Almirall, Amgen, Boehringer Ingelheim, Leo, Lilly, Novartis and UCB LK Nil. PSH Has received research grant income from AbbVie, Janssen and Novartis; has received honoraria or consultation fees from Celgene and Galapagos; and has received honoraria or consultation fees paid to charity from AbbVie, Amgen, Pfizer and UCB.
